Fueling the Viral Fire With mRNA

2021 John A. Catanzaro, CEO of Neo7Logix

In the next few months to years, the existing trend of mRNA vaccines will reveal the shortfalls associated with their current designs. Currently, greater than 60% of the population affected by the COVID global outbreak are refusing the mRNA-based vaccines over concerns of safety and long-term adverse health effects.